The histone methyltransferase SMYD2 is a novel therapeutic target for the induction of apoptosis in ovarian clear cell carcinoma cellsMachiko Kojima, Tomoyuki Fujii|Oncology Letters|2020Cited by 31
The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferationMachiko Kojima, Tomoyuki Fujii|BMC Cancer|2019Cited by 17